This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
    • Politics
    • Transport
    • Lifestyle
    • Community
    • Business
    • Crime
    • Environment
    • Health
    • Education
    • Harrogate
    • Ripon
    • Knaresborough
    • Boroughbridge
    • Pateley Bridge
    • Masham
  • What's On
  • Offers
  • Latest Jobs

Interested in advertising with us?

Advertise with us

  • News & Features
  • Your Area
  • What's On
  • Offers
  • Latest Jobs
  • Politics
  • Transport
  • Lifestyle
  • Community
  • Business
  • Crime
  • Environment
  • Health
  • Education
Advertise with us
Subscribe
  • Home
  • Latest News

We want to hear from you

Tell us your opinions and views on what we cover

Contact us
Connect with us
  • About us
  • Advertise your job
  • Correction and complaints
Download on App StoreDownload on Google Play Store
  • Terms and Conditions
  • Privacy Statement
  • Comments Participation T&Cs
Trust In Journalism

Copyright © 2020 The Stray Ferret Ltd, All Rights Reserved

Site by Show + Tell

Thank you for your interest in this story

To continue reading this article, subscribe to the Stray Ferret for as little as £1 a week

    Already a subscriber? Log in here.

    05

    Jul 2021

    Last Updated: 05/07/2021
    Health
    Health

    Harrogate woman denied new drugs for chronic migraines

    by Tamsin O'Brien

    | 05 Jul, 2021
    Comment

    0

    Tiffany Snowden suffers from 20 migraine days a month which can last up to 48 hours at a time. The NHS in England is not prescribing new drugs that she says might help her. Her only other option is to buy the medicine at £350 per month. 

    tiffany-snowden

    A woman from Harrogate who suffers up to 20 migraine days a month says she isn't being prescribed a set of drugs that could help her.

    The National Institute for Health and Care Excellence (NICE) approved the anti-CGRP drugs for use in March 2020 yet Tiffany Snowden says the NHS in England still isn't prescribing them.

    Anti-CGRP drugs are the first medication created specifically for episodic or chronic migraines.

    Ms Snowden says only other option being to buy the medicine herself at a cost of £350 per month.

    Before discovering the anti-CGRP medication Mrs Snowden had been prescribed three different medications, but Mrs Snowden said they made her feel very ill.





    Read More:



    • Harrogate hospital chief executive racially abused by England fan

    • Forty two new positive covid cases in the Harrogate district





    Having found out that the drugs have been available in England and Wales since March 2020, Ms Snowden filed a freedom of information request to Harrogate and District NHS Foundation Trust asking how many people had been prescribed them in the district.

    The trust did not meet the deadline to return the information to Ms Snowden.  A spokesperson told the Stray Ferret:

    “A response to Tiffany’s Freedom of Information request will be with her shortly. We are working hard to respond to FOI requests but owing to operational pressures during the covid pandemic, replies may be delayed.
    “While we are unable to comment on individual cases, anti-CGRP drugs, which currently include erenumab, galcanezumab and fremanezumab, are available as potential treatment for patients accessing services for episodic and chronic migraine. That is for those patients that fulfil the NICE criteria for their use."


    In response, Ms Snowden — who says she does fit the NICE criteria — said:

    "That is great news that the hospital is able to prescribe those drugs under the NHS but it does not change the difficulty patients in our district are having in accessing them".


    The NHS North of England Commissioning Support Unit has said the drugs will be available from this month in England and Wales.